Proteomic and metabolomic characterization of cardiac tissue in acute myocardial ischemia injury rats

PLoS One. 2020 May 4;15(5):e0231797. doi: 10.1371/journal.pone.0231797. eCollection 2020.

Abstract

The pathological process and mechanism of myocardial ischemia (MI) is very complicated, and remains unclear. An integrated proteomic-metabolomics analysis was applied to comprehensively understand the pathological changes and mechanism of MI. Male Sprague-Dawley rats were randomly divided into a mock surgery (MS) group and an MI group. The MI model was made by ligating the left anterior descending coronary artery, twenty-four hours after which, echocardiography was employed to assess left ventricular (LV) function variables. Blood samples and left ventricular tissues were collected for ELISA, metabolomics and proteomics analysis. The results showed that LV function, including ejection fraction (EF) and fractional shortening (FS), was significantly reduced and the level of cTnT in the serum increased after MI. iTRAQ proteomics showed that a total of 169 proteins were altered including 52 and 117 proteins with increased and decreased expression, respectively, which were mainly involved in the following activities: complement and coagulation cascades, tight junction, regulation of actin cytoskeleton, MAPK signaling pathway, endocytosis, NOD-like receptor signaling pathway, as well as phagosome coupled with vitamin digestion and absorption. Altered metabolomic profiling of this transition was mostly enriched in pathways including ABC transporters, glycerophospholipid metabolism, protein digestion and absorption and aminoacyl-tRNA biosynthesis. The integrated metabolomics and proteomics analysis indicated that myocardial injury after MI is closely related to several metabolic pathways, especially energy metabolism, amino acid metabolism, vascular smooth muscle contraction, gap junction and neuroactive ligand-receptor interaction. These findings may contribute to understanding the mechanism of MI and have implication for new therapeutic targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Animals
  • Male
  • Metabolomics
  • Myocardial Infarction / metabolism
  • Myocardial Infarction / pathology
  • Myocardial Ischemia / metabolism*
  • Myocardial Ischemia / pathology
  • Myocardium / chemistry
  • Myocardium / metabolism*
  • Myocardium / pathology
  • Proteomics
  • Rats
  • Rats, Sprague-Dawley
  • Ventricular Dysfunction, Left / metabolism
  • Ventricular Dysfunction, Left / pathology

Grants and funding

This work was supported by the following fundings:Prof. LSF, Natural Science Foundation of China (No. 81774210); Prof. GYH, Natural Science Foundation of China (No.81674063, 81974583) and Jiangsu Provincial Leading Talents in Chinese Medicine (No.SLJ0226); Dr. ZHR, Natural Science Foundation of China (No.81704169) and the Natural Science Foundation of Jiangsu Province (No.BK20171067). All funders were participated the study, specifically, Hong-Ru Zhang revised the paper, Yi-Huang Gu and Sheng-Feng Lu designed the study. and revised the paper.